Department of Anorectal, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, No.6 Huanghe Road, Changshu, 215500, China.
Department of Anorectal, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, 215000, China.
Langenbecks Arch Surg. 2023 Aug 24;408(1):332. doi: 10.1007/s00423-023-03081-2.
This study aimed to explore the efficiency and safety of modified tissue-selecting therapy stapler combined with complete anal canal epithelial preservation operation (M-TST-CACP) in the treatment of circumferential mixed hemorrhoids.
This was a single-center, statistical analyst-blinded, randomized controlled trial (RCT). A total of 306 patients were finally included for analysis. The efficiency (efficacy, recurrence, anal smoothness, quality of life, and wound healing time) and safety (anal incontinence, pain level, anal stenosis, urinary retention, perianal edema, and postoperative bleeding) were evaluated. The statistical difference in continuous data between M-TST-CACP group and procedure for prolapse and hemorrhoids (PPH) group was compared using t-test or Mann-Whitney U test. The statistical difference in counting data between the two groups were compared using Pearson χ test. Difference within each group in different time points was evaluated using repeated-measures analysis of variance.
M-TST-CACP group showed a higher cure rate (6 months: 74.51% vs. 64.71%, P = 0.044), lower recurrence (6 months: 0% vs. 4.58%, P = 0.015; 12 months: 0.65% vs. 5.88%, P = 0.010), lower anal incontinence score (1 month: 1.29 ± 1.17 vs. 1.93 ± 1.33; 3 months: 1.07 ± 0.87 vs. 1.59 ± 1.01; 6 months: 0.58 ± 0.61 vs. 1.00 ± 0.90; all P < 0.001), and lower rate of anal stenosis (1 month: 0% vs. 7.84%; 3 months: 0% vs. 9.80%; both P < 0.001) than the PPH group.
M-TST-CACP had better efficiency and safety than the PPH, which could be a reasonable adoption for the surgeons to treat circumferential mixed hemorrhoids.
本研究旨在探讨改良组织选择性痔吻合器切除术联合完整肛管上皮保留术(M-TST-CACP)治疗环状混合痔的疗效和安全性。
这是一项单中心、统计分析师设盲、随机对照试验(RCT)。最终共有 306 例患者纳入分析。评估了 M-TST-CACP 组和痔环切吻合术(PPH)组的疗效(疗效、复发、肛门平整度、生活质量和伤口愈合时间)和安全性(肛门失禁、疼痛程度、肛门狭窄、尿潴留、肛周水肿和术后出血)。使用 t 检验或 Mann-Whitney U 检验比较 M-TST-CACP 组和 PPH 组之间连续数据的统计学差异。使用 Pearson χ 检验比较两组计数数据的统计学差异。使用重复测量方差分析评估每组不同时间点的差异。
M-TST-CACP 组的治愈率更高(6 个月:74.51% vs. 64.71%,P=0.044),复发率更低(6 个月:0% vs. 4.58%,P=0.015;12 个月:0.65% vs. 5.88%,P=0.010),肛门失禁评分更低(1 个月:1.29±1.17 vs. 1.93±1.33;3 个月:1.07±0.87 vs. 1.59±1.01;6 个月:0.58±0.61 vs. 1.00±0.90;均 P<0.001),肛门狭窄发生率更低(1 个月:0% vs. 7.84%;3 个月:0% vs. 9.80%;均 P<0.001),优于 PPH 组。
M-TST-CACP 的疗效和安全性优于 PPH,可作为治疗环状混合痔的合理选择。